LTRN Lantern Pharma Inc.

15.3
-0.43  -3%
Previous Close 15.73
Open 15.69
52 Week Low 10.4
52 Week High 24.84
Market Cap $95,128,928
Shares 6,217,577
Float 2,301,815
Enterprise Value $79,098,068
Volume 22,965
Av. Daily Volume 33,609
Stock charts supplied by TradingView

Drug Pipeline

Drug Stage Notes
LP-300
Non-small cell lung cancer (NSCLC)
Phase 2
Phase 2
Phase 2 trial planned.
LP-100
Hormone-refractory prostate cancer (MHRPC)
Phase 2
Phase 2
Phase 2 trial ongoing.